Genedrive Plc
GDR.L · LSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.03 | -0.05 |
| FCF Yield | -66.22% | -42.79% | -28.61% | -8.32% |
| EV / EBITDA | -1.02 | 0.38 | -3.25 | -4.58 |
| Quality | ||||
| ROIC | -77.09% | -51.58% | -123.14% | -100.27% |
| Gross Margin | 87.71% | 50.95% | 50.42% | -314.71% |
| Cash Conversion Ratio | 0.70 | 1.31 | 0.26 | 1.18 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.90% | -27.14% | -45.43% | -54.63% |
| Free Cash Flow Growth | -127.14% | 44.02% | -73.87% | 43.05% |
| Safety | ||||
| Net Debt / EBITDA | 0.84 | 0.99 | 0.48 | 0.75 |
| Interest Coverage | 0.00 | -738.25 | -294.88 | -169.60 |
| Efficiency | ||||
| Inventory Turnover | 0.12 | 0.34 | 0.22 | 0.27 |
| Cash Conversion Cycle | -833.79 | -155.36 | 337.61 | 59.36 |